Latest News

Nvidia's 55.6% net margin dwarfs Applied Materials' 24.7%, but one trades at a steep valuation premium while the other faces customer concentration risk.

Alnylam Pharmaceuticals (NASDAQ:ALNY) outlined its strategy for advancing zilebesiran, an investigational RNA interference, or RNAi, therapy designed to provide sustained blood-pressure control with twice-yearly dosing for people with uncontrolled hypertension and elevated cardiovascular risk. Duri

The Federal Open Market Committee (FOMC) just raised interest rates for the first time in three years.

The language learning platform provider reported a notable insider sale as its stock plunged 47% over the past year.

After the sale, West still held $6.1 million in stock.

Oracle's AI spending spree needs power and cooling to match. Two industrial stocks are already cashing in on that demand.

IAMGold (TSX:IMG) stock looks way too cheap to ignore despite euphoric five-year gains in the books.

Brookfield Asset Management (NYSE:BAM) used its 2026 Investor Day to outline plans to double fee-bearing capital by 2031, supported by fundraising across flagship funds, complementary strategies, insurance capital and private wealth products. Management also emphasized the July acquisition of the re

These Canadian stocks offer strong growth potential, with a few pulling back from their highs and now presenting attractive entry points.

Uncover the best performing gold stocks from the 2026 TSX30. Find out which gold mining companies have shown impressive returns.

Following a brutal 2026, the five-year case comes down to reaccelerating software growth and a 31-year dividend streak.

Comparing this relatively small part of Berkshire's business to its publicly traded counterparts illustrates just how enormous the conglomerate has become.

Definium Therapeutics (NASDAQ:DFTX) reported positive top-line results from Panorama, its second Phase III study of DT120 ODT 100 mcgs in generalized anxiety disorder, or GAD. The company said the single-dose treatment met its primary endpoint and all key secondary endpoints, adding to positive pivo

Turn Your Phone Time Into Real CashMobile earpiece experience evolved far beyond simple communication devices or tools for social media scrolling. Today, s

The defense industry environment is changing, and it's putting pressure on traditional ways of doing business.

One fuel cell stock is chasing AI power demand with billions in backing. Another is staying out of the race entirely.

The risk of a sudden reversal in AI growth looms large over Oracle stock.

Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company expects fiscal 2027 to extend the broad operating momentum it generated in fiscal 2026, with all five operating segments positioned for what he described as a “constructive” period. Speaking at the Morgan Stanley Global Healthcare Confere

A CEO apologizing for a chip shortage sounds like bad news -- unless fuller factories are a big part of the profit story.

This ETF provides the kind of growth and income profile that could do really well.

Cathie Wood remains very bullish on Tesla stock.

Buying a home is a major financial decision, and choosing the right mortgage can affect both upfront expenses and long-term housing costs. For eligible vet

Bank of New York Mellon (NYSE:BNY) Chief Financial Officer Dermot McDonogh said the company’s recent progress has been driven by expense discipline, a revamped commercial model and a cultural shift aimed at making the firm more ambitious and client-focused. Speaking at an investor conference, McDon

These pipeline companies are cashing in on the AI data center power boom.

Yes, investors should be worried about an AI bubble because Wall Street has a long history of going to extremes.